Request a Quote

Cyprotex Highlights - June 2022

2022 Header

The webinar presents the most recent updates in CYP induction, as well as a comprehensive overview of data interpretation, comparing basic models including R3 and RIS for predicting CYP3A4 DDI risk.

Presented by our in-house expert, Katie Plant, the webinar will be broadcast on 6th July 2022 and is free to attend.

Register now

Our latest blog article examines the scientific work behind our recent poster “Application of Acquity Premier Technology for Enhanced Chromatographic Performance of Pharmaceutical Compounds in RP-UPLCMS”. It presents exciting new advances in chromatographic performance and sensitivity for ADME screening.

Read the blog

Download the poster

From 30th June - 2nd July 2022, Cyprotex are attending the 49th Annual Meeting of the Japanese Society of Toxicology in Sapporo, Japan!

Masaaki Yatsu and Tim Potter will be at the in-person event; you can find them at the CMIC booth.

Find out more

Arrange a meeting

Read the latest news from parent company, Evotec:

  • Alongside other life-science partners, Evotec launches CARMA FUND I
  • Evotec enters into drug discovery collaboration with Janssen
  • Evotec partner Exscientia reports data from Phase 1 study

Read the press releases

Read more from Evotec, Cyprotex and Just - Evotec Biologics in the Science Pool blog:

Read the blog

Contact us


Contact us to discuss your ADME Tox issues or request a quote

Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683

or fill out the form below:


Download file